Skip to main navigation
  • About
    • Our Vision
    • Our Approach
    • Our Team
  • Pipeline
    • DARE-BV1
    • OVAPRENE®
    • Sildenafil Cream, 3.6%
  • Partners
  • Consumers
  • Investors
    • Overview
    • Press Releases
    • Presentation, Events & Webcasts
    • Stock Information
      • Stock Quote & Chart
      • Historic Stock Lookup
      • Analyst Coverage
    • Financial Information
      • Financials Overview
      • SEC Filings
      • Annual Reports & Proxies
      • Quarterly Results
    • Corporate Governance
      • Documents & Charters
      • Board of Directors
      • Management
    • Contact
  • Careers
  • Contact Us
    Dare Biosciences
    • Investors
    • Press releases
    • Presentations, Events & Webcasts
    • Stock information
    • Financial Information
      • SEC Filings
      • Annual Reports & Proxies
      • Quarterly Results
    • Corporate governance
    • Contact

    SEC Filings

    SEC Filings

    Filing date Form Description View
    04-01-2020 SC 13D/A

    An amendment to a SC 13D filing

    View HTML
    0001493152-20-005629.pdf
    0001493152-20-005629.xls
    03-30-2020 S-8

    Securities offered to employees pursuant to employee benefit plans

    View HTML
    0001401914-20-000044.pdf
    0001401914-20-000044.xls
    03-27-2020 10-K

    Annual report which provides a comprehensive overview of the company for the past year

    View HTML
    0001401914-20-000042.pdf
    0001401914-20-000042.xls
    EX-101.INS - XBRL INSTANCE DOCUMENT
    03-16-2020 8-K

    Report of unscheduled material events or corporate event

    View HTML
    0001401914-20-000038.pdf
    0001401914-20-000038.xls
    03-09-2020 3

    Initial filing by director officer or owner of more than ten percent.

    View HTML
    0001401914-20-000028.pdf
    0001401914-20-000028.xls
    03-09-2020 4

    Statement of changes in beneficial ownership of securities

    View HTML
    0001401914-20-000032.pdf
    0001401914-20-000032.xls
    03-09-2020 4

    Statement of changes in beneficial ownership of securities

    View HTML
    0001401914-20-000034.pdf
    0001401914-20-000034.xls
    03-09-2020 4

    Statement of changes in beneficial ownership of securities

    View HTML
    0001401914-20-000036.pdf
    0001401914-20-000036.xls
    02-21-2020 424B5

    Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

    View HTML
    0001401914-20-000024.pdf
    02-21-2020 SC 13D/A

    An amendment to a SC 13D filing

    View HTML
    0001401914-20-000026.pdf
    0001401914-20-000026.xls

    Pagination

    • First page « First
    • Previous page ‹ Previous
    • …
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Current page 7
    • Page 8
    • Page 9
    • Page 10
    • Page 11
    • …
    • Next page Next ›
    • Last page Last »

    Data provided by Kaleidoscope.

    • Request email alerts |
    • Print this page |
    • Search investor site |

    © 2021 by Daré Bioscience | Daré Bioscience® is a registered trademark of Daré Bioscience, Inc.

    Privacy Policy | Terms of Service | COI Policy |

    Scroll to top